Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Pediatric Endocrinology and Metabolism

Editor-in-Chief: Kiess, Wieland

Ed. by Bereket, Abdullah / Darendeliler, Feyza / Dattani, Mehul / Gustafsson, Jan / Luo, Fei Hong / Mericq, Veronica / Toppari, Jorma


IMPACT FACTOR 2018: 1.239

CiteScore 2018: 1.22

SCImago Journal Rank (SJR) 2018: 0.507
Source Normalized Impact per Paper (SNIP) 2018: 0.562

Online
ISSN
2191-0251
See all formats and pricing
More options …
Volume 32, Issue 1

Issues

A Turkish girl with H syndrome: stunted growth and development of autoimmune insulin dependent diabetes mellitus in the 6th year of diagnosis

Can Ozlu / Gul Yesiltepe Mutlu
  • Corresponding author
  • Koc University School of Medicine, Istanbul 34010, Turkey
  • Department of Pediatric Endocrinology, Koc University Hospital, Davutpasa Street No 4, Zeytinburnu 34010, Turkey, Phone: +905057235725
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Sukru Hatun
  • Koc University School of Medicine, Istanbul, Turkey
  • Department of Pediatric Endocrinology, Koc University Hospital, Zeytinburnu, Turkey
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2018-12-05 | DOI: https://doi.org/10.1515/jpem-2018-0380

Abstract

Background

H syndrome ([OMIM] 602782) is an autosomal recessive disorder with systemic manifestations and characteristic skin lesions, caused by mutations of the SLC29A3 gene. Short stature and diabetes mellitus are the major endocrine problems related to H syndrome, however, clear data from clinical follow-up of H syndrome patients is lacking in the literature.

Case presentation

Here, we present follow-up of a Turkish girl diagnosed with H syndrome at the age of 10 with a homozygous 310(c.933T>A, p.C310X) early stop codon mutation on exon 6 of the SLC29A3 gene. She had severe short stature non-responsive to growth hormone (GH) treatment and gluten-free diet despite low GH levels and celiac antibody positivity. She developed insulin dependent diabetes mellitus (IDDM) symptoms 6 years after the initial diagnosis.

Conclusions

H syndrome patients can develop IDDM years after characteristic symptoms. Short stature in H syndrome patients may not respond to GH replacement or gluten-free diet alone.

Keywords: diabetes mellitus; H syndrome; short stature

References

  • 1.

    Molho-Pessach V, Ramot Y, Camille F, Doviner V, Babay S, et al. The H syndrome: the first 79 patients. J Am Acad Dermatol 2014;70:80–8.CrossrefWeb of ScienceGoogle Scholar

  • 2.

    Hsu C-L, Lin W, Seshasayee D, Chen YH, Ding X, et al. Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis. Science 2011;335:89–92.Web of SciencePubMedGoogle Scholar

  • 3.

    Mutlu GY, Ramot Y, Babaoglu K, Altun G, Zlotogorski A, et al. Agenesis of the inferior vena cava in H syndrome due to a novel SLC29A3 mutation. Pediatr Dermatol 2013;30:e70–3.Web of ScienceCrossrefGoogle Scholar

  • 4.

    Mistry A, Parry D, Matthews B, Laws P, Goodfield M, et al. A case of SLC29A3 Spectrum disorder-unresponsive to multiple immunomodulatory therapies. J Clin Immunol 2016;36:429–33.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 5.

    Bloom JL, Lin C, Imundo L, Guthery S, Stepenaskie S, et al. H syndrome: 5 new cases from the United States with novel features and responses to therapy. Pediatr Rheumatol 2017;15(1):76.CrossrefWeb of ScienceGoogle Scholar

  • 6.

    Barstow C, Rerucha C. Evaluation of short and tall stature in children. Am Fam Physician 2015;92:43–50.Google Scholar

  • 7.

    Broshtilova V, Ramot Y, Molho-Pessach V, Zlotogorski A. Diabetes mellitus may be the earliest and sole manifestation of the H syndrome. Diabet Med 2009;26:1179–80.CrossrefGoogle Scholar

  • 8.

    Elbarbary NS, Tjora E, Molnes J, Lie BA, Habib MA, et al. An Egyptian family with H syndrome due to a novel mutation in SLC29A3 illustrating overlapping features with pigmented hypertrichotic dermatosis with insulin-dependent diabetes and Faisalabad histiocytosis. Pediatr Diabetes 2012;14:466–72.Google Scholar

  • 9.

    Hussain K, Padidela R, Kapoor RR, James C, Banerjee K, et al. Diabetes mellitus, exocrine pancreatic deficiency, hypertrichosis, hyperpigmentation, and chronic inflammation: Confirmation of a syndrome. Pediatr Diabetes 2008;10:193–7.PubMedWeb of ScienceGoogle Scholar

  • 10.

    Cliffe ST, Kramer JM, Hussain K, Robben JH, de Jong EK, et al. SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway. Hum Mol Genet 2009;18:2257–65.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 11.

    Prendiville J, Rogers M, Kan A, de Castro F, Wong M, et al. Pigmented hypertrichotic dermatosis and insulin dependent diabetes: manifestations of a unique genetic disorder? Pediat Derm 2007;24:101–7.CrossrefGoogle Scholar

  • 12.

    Jesus JD, Imane Z, Senée V, Romero S, Guillausseau PJ, et al. SLC29A3 mutation in a patient with syndromic diabetes with features of pigmented hypertrichotic dermatosis with insulin-dependent diabetes, H syndrome and Faisalabad histiocytosis. Diabetes Metab 2013;39:281–5.Web of ScienceCrossrefGoogle Scholar

  • 13.

    Marina S, Broshtilova V. POEMS in childhood. Pediatr Dermatol 2006;23:145–8.CrossrefPubMedGoogle Scholar

  • 14.

    Tekin B, Atay Z, Ergun T, Can M, Tuney D, et al. H syndrome: a multifaceted histiocytic disorder with hyperpigmentation and hypertrichosis. Acta Dermato Venereologica 2015; 95:1021–3.PubMedCrossrefGoogle Scholar

About the article

Received: 2018-08-28

Accepted: 2018-11-11

Published Online: 2018-12-05

Published in Print: 2019-01-28


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Journal of Pediatric Endocrinology and Metabolism, Volume 32, Issue 1, Pages 89–93, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: https://doi.org/10.1515/jpem-2018-0380.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in